Efficacy and Safety of Alirocumab in Patients With or Without Prior Coronary Revascularization: Pooled Analysis of Eight ODYSSEY Phase 3 Trials
Atherosclerosis - Netherlands
doi 10.1016/j.atherosclerosis.2018.07.010
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV